Possible retroviral origin of prion disease: Could prion disease be reconsidered as a preleukemia syndrome?

Biomedicine and Pharmacotherapy

Volumn 53, Issue 1, 1999, Pages 47-53

  Labat, M L ^a  

^a ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

Author keywords

Gliosis, fibrosis; Immune defect; Monocytes; Preleukemia; Prion disease; Retrovirus

Indexed keywords

AMYLOID; PRION PROTEIN; RNA DIRECTED DNA POLYMERASE;

AMYLOIDOSIS; ARTICLE; CELL PROLIFERATION; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENE MUTATION; LEUKEMIA; MONOCYTE; MURINE LEUKEMIA VIRUS; NEUROPATHOLOGY; PRELEUKEMIA; PRION DISEASE; PRIORITY JOURNAL; RETROVIRUS; SCRAPIE; VESICULAR STOMATITIS VIRUS; VIRUS ISOLATION; VIRUS RECOMBINATION;

EID: 0033081481     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(99)80060-2     Document Type: Article

References (60)

1. Aguzzi A. Neuro-immune connection in spread of prions in the body. The Lancet 1997 ; 349 : 742-3.
2. Bendheim PE, Barry RA, De Armond SJ, Stites DP, Prusiner SB. Antibodies to scrapie prion-protein. Nature 1984 ; 310 : 418-21.
3. Bilelle JA, Pitts OM, Zachary JF. Ocular infection with a murine neurovirulent retrovirus does not cause retinal degeneration. Ophthalmol Vis Sci 1992 ; 33 : 384-9.
4. Bockman JM, Kingsbury DT, McKinley MP, Bendheim PE, Prusiner SB. Creutzfeldt-Jakob disease prion-proteins in human brains. New Eng J Med 1985 ; 312 : 73-8.
5. Bringuier AF, Séébold-Choqueux CH, Moricard Y, Simmons DJ, Milhaud G, Labat ML. T-lymphocyte control of HLA-DR blood monocytes differentiation into neo-fibroblasts. Further evidence of pluripotential secreting functions of HLA-DR monocytes, involving not only collagen but also uromodulin, amyloid-b peptide, a-fetoprotein and carcinoembryonic antigen. Biomed Pharmacother 1992 ; 46 : 91-108.
6. Bringuier AF, Labat ML. Retroviral expression in a patient who has paraarticular ossification. Clin Orthop 1995 ; 313 : 239-52.
7. Burny A, Bruxk C, Chantrenne H, et al. Bovine leukemia virus: Molecular biology and epidemiology. In: Klein G, ed. Viral Oncology. New York: Raven Press; 1980. p. 231-89.
8. Caughey B. Scrapie-associated PrP accumulation and agent replication: Effects of sulphate glycosaminoglycan analogues. Phil Trans Royal Soc London - Series B. Biol Sci 1994 ; 343 : 399-404.
9. Caughey B, Chesebro B. Prion protein and the transmissible spongiform encephalopathies. Cell Biology 1997 ; 7 : 56-62.
10. Czub M, Czub S, Rappold M, Mazgareanu S, Schwender S, Demuth M, et al. Murine leukemia virus induce neurodegeneration of rats. Enhancement of neuropathogenicity correlates with enhanced viral tropism for macrophages, microglia and brain vascular cells. Virology 196 ; 214 : 239-44.
11. Dealler S. The key must fit: Macrophages transport prion infection to the central nervous system and may determine the sites of infection within it. Med Hypotheses 1997 ; 49 : 213-20.
12. DesGroseillers L, Barrette M, Jolicoeur P. Physical mapping of the paralysis inducing determinant of a wild mouse ecotropic neurotropic virus. J Virol 1984 ; 52 : 356-63.
13. Ecklund CM, Kennedy RC, Hadlow WJ. Pathogenesis of scrapie infection in the mouse. J Infect 1967 ; 117 : 15-22.
14. Emi N, Friedmann T, Yee JK. Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus. J Virol 1991 ; 65 : 1202-7.
15. Gajdusek DC. Slow virus disorders. In: Liberski PV, ed. Light and Electron Microscopy Neuropathology of Slow Virus Disorders. Boca Raton: CRC Press; 1993. p. 1-31.
16. Gajdusek DC, Rogers RG, Basnight M, et al. Transmission experiments with Kuru in chimpanzees and the isolation of latent viruses from the explanted tissue of affected animals. Ann NY Acad Sci 1969 ; 162 : 529.
17. Gardner MB, Henderson BE, Officer JE, Rongey RW, Parker JC, Oliver C, et al. A spontaneous lower motor neuron disease apparently caused by endogenous type C RNA virus in wild mice. J Natl Cancer Inst 1973 ; 51 : 1243-54.
18. Gardner MB, Rongey RW, Arnstein P, Estes JD, Sarma P, Huebner RJ, et al. Experimental transmission of feline fibrosarcoma to cats and dogs. Nature 1970 : 807-8.
19. Hill AF, Zeidler M, Ironside J, Collinge J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997 ; 349 : 99.
20. Hoffman PM, Cimino EF, Robbins DS, Broadwell RD, Powers JM, Ruscetti SK. Cellular tropism and localization in the rodent nervous system of a neuropathogenic variant of friend murine leukemia virus. Lab Invest 1992 ; 67 : 314-21.
21. Huang AS, Besmer P, Chu L, Baltimore D. Growth of pseudotypes of vesicular stomatitis virus with N-tropic murine leukemia virus coats in cells resistant to N-tropic viruses. J Virol 1973 ; 12 : 659-62.
22. Jähner D, Jaenisch R. Integration of Moloney leukaemia virus into the germ line of mice: Correlation between site of integration and virus activation. Nature 1985 ; 287 : 456-8.
23. Kai K, Furata T. Isolation of paralysis-inducing murine leukemia viruses from Friend virus passaged in rats. J Virol 1984 ; 50 : 970-3.
24. Labat ML. A new approach to the study of the origin of genetic diseases: Retroviral etiology of osteopetrosis. Biomed Pharmacother 1991 ; 45 : 23-7.
25. Labat ML. Retroviruses and bone diseases. Clin Orthop Rel Res 1996 ; 326 : 287-309.
26. Labat ML, Bringuier AF, Arys-Philippart C, Arys A, Wellens F. Monocytic origin of fibrosis. In vitro transformation of HLA-DR monocytes into neo-fibroblasts: Inhibitory effect of alltrans retinoic acid on this process. Biomed Pharmacother 1994 ; 48 : 103-11.
27. Labat ML, Bringuier AF, Chandra A, Einhorn TA, Chandra P. Retroviral expression in mononuclear blood cells isolated from a patient with osteopetrosis (Albers-Schönberg disease). J Bone Miner Res 1990 ; 5 : 425-35.
28. Labat ML, Bringuier AF, Séébold C, Moricard Y, Meyer-Mula C, Laporte P, et al. Monocytic origin of fibroblasts: Spontaneous transformation of blood monocytes into neo-fibroblastic structures in osteomyelosclerosis and Engelmann's disease. Biomed Pharmacother 1991 ; 45 : 289-99.
29. Labat ML, Bringuier AF, Séébold-Choqueux C, Moricard Y, Meyer-Mula C, Delépine N, et al. Possible monocytic origin of chondrosarcoma: In vitro transdifferentiation of HLA-DR blood monocyte-like cells from a patient wit chondrosarcoma, into neo-fibroblasts and chondrocyte-like cells. Biomed Pharmacother 1997 ; 51 : 79-93.
30. Labat ML, Bringuier AF, Séébold-Choqueux C, Moricard Y, Rault G, Jehanne M, et al. Cystic fibrosis: Production of high levels of uromodulin-like protein by HLA-DR blood monocytes differentiating towards a fibroblastic phenotype. Biomed Pharmacother 1991 ; 45 : 387-402.
31. Labat ML, Duchossoy Y, Chaumeil C, Brugère-Picoux J, Brugère H, Gavarol D, Quintin-Colonna F. Unpublished results.
32. Labat ML, Gouhier N, Pouchelet M. Cinemicrographic study of the transdifferentiation of monocyte-like cells into cells of the mesenchymal pool. Bone 1998 ; suppl T : 141 (abstract).
33. Lasmézas CI, Cesbron JY, Deslys JP, et al. Immune system dependent and independent replication of the scrapie agent. J Virol 1996 ; 70 : 1291-5.
34. Lasmézas CI, Deslys JP, Robain O, Jaegly A, Beringue V, Peyrin JM, et al. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 1997 ; 275 : 402-5.
35. Mabbott NA, Brown KL, Bruce ME. T-lymphocyte activation and the cellular form of the prion protein PrP. Biochem Soc Trans 1997 ; 25 : 307S.
36. Marsh RF, Burger D, Hanson R. Transmissible mink encephalopathy behavior of the disease agent in mink. Am J Vet Res 1969 ; 30 : 1637-42.
37. Masters CL, Gajdusek DC, Gibbs CJ. Creutzfeldt-Jakob disease virus isolation from Gerstmann-Straussler-Scheinker syndrome with an analysis of the serious forms of amyloid plaque deposition in the virus induced spongiform encephalopathies. Brain 1981 ; 104 : 559-88.
38. Masuda M, Hoffman PM, Ruscetti SK. Viral determinants that control the neuropathogenicity of PVC-211 murine leukemia virus in vivo determine brain capillary endothelial cell tropism of the virus in vitro. J Virol 1993 ; 67 : 4580-7.
39. McFarlin DE, Koprowski H. Neurological disorders associated with HTLV-1. Curr Top Microbiol Immunol 1990 ; 160 : 99-119.
40. Menke DM, Griesser H, Araujo I, Foss H-D, Herbst H, Banks PM, et al. Inflammatory pseudotumors of lymph node origin show macrophage-derived spindle cells and lymphocyte-derived cytokine transcripts without evidence of T-cell receptor gene rearrangements. Hematopathology 1996 ; 105 : 430-9.
41. Miller JM, Miller MD, Olson C, Gillette KG. Virus-like particles in phytohemagglutinin-stimulated lymphocyte cultures with reference to bovine lymphosarcoma. J Natl Cancer Inst 1969 ; 43 : 1459-62.
42. Murdoch C, Sklaviakis T, Manuelidis EE, Manuelidis L. Potential RNA transcripts in infectious fractions of CJD. J Virol 1990 ; 64 : 1477-86.
43. Oldstone MBA, Lampert PW, Lee S, FJ Dixon. Pathogenesis of the slow disease of the central nervous system associated with WM 1504 E virus. I. Relationship of strain susceptibility and replication to disease. Am J Pathol 1977 ; 88 : 193-212.
44. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JE, Gallo RC. Detection and isolation of type C-retrovirus particles from fresh and cultured lymphocytes from a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980 ; 77 : 7415-19.
45. Potyid JL, Czub D, Garon CF, McAttee FJ. Neurodegenerative disease induced by the wild mouse ecotropic retrovirus is markedly accelerated by long terminal repeat and gag-pol sequences from nondefective Friend murine leukemia virus. J Virol 1990 ; 64 : 1648-56.
46. Portis JL. Wild mouse retrovirus: Pathogenesis. Curr Top Microbiol Immunol 1990 ; 160 : 11-27.
47. Price RW. Neurological complications of HIV infection. Lancet 1996 ; 348 : 445-52.
48. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982 ; 216 : 136-44.
49. Prusiner SB, Groth DF, Cochran SP, Masiarz FR, McKinLey MP, Martinez HM. Molecular properties, partial purification and assay by incubation period measurement of the scrapie agent. Biochemistry 1980 ; 19 : 4883-91.
50. Robain O, Chany-Fournier F, Cerutti I, Mazlo M, Chany C. Role of VSV G antigen in the development of experimental spongiform encephalopathy in mice. Acta Neuropathol 1986 ; 70 : 220-6.
51. Roberts GW, Lofthouse R, Brown P, Crow TJ, Barry RA, Prusiner SB. Prion-protein immunoreactivity in human transmissible dementia (letter). New Eng J Med 1986 ; 315 : 1231-3.
52. Rojko JL, Olsen RG. The immunobiology of the feline leukemia virus. In: Advances in Veterinary Immunology. FJ Bourne, NT Gorman, eds. Amsterdam: Elsevier; 1983. p. 107-65.
53. Seilhean D, Duyckaeerts C, Hauw JJ. Insomnie fatale familiale et maladies à prions. Rev Neur 1995 ; 151 : 225-30.
54. Snyder SP, Theilen GH. Transmissible feline fibrosarcoma. Nature 1969 ; 221 : 1074-5.
55. Wells GA, Scott AC, Johnson CT, Gunning RF, Hancock RD, Jeffrey M, et al. A novel progressive spongiform encephalopathy in cattle. Vet Rec 1987 ; 121 : 419-20.
56. Westarp ME, Westphal KP, Clausen J, Rasmussen HB, Hobb-Jorgensen R, Fohring B, et al. Retroviral interference with neurotrophic signaling in human motor neuron disease. Clin Physiol Biochem 1993 ; 10 : 1-7.
57. Wiley CA, Gardner M. The pathogenesis of murine retroviral infection of the central nervous system. Brain Path 1993 ; 3 : 123-8.
58. Wong PK. Moloney murine leukemia virus temperature-sensitive mutants: A model for retrovirus-induced neurologic disorders. Curr Top Microbiol Immunol 1990 ; 160 : 29-60.
59. Yu YE, Choe W, Zhang W, Stoica G, Wong PKY. Development of pathological lesions in the central nervous system of transgenic mice expressing the env gene of ts1 Moloney murine leukemia virus in the absence of the viral gag and pol genes and viral replication. J Neurovirology 1997 ; 3 : 274-82.
60. Zavada J. Pseudotype of vesicular stomatitis virus with the coat of murine leukemia and avian myeloblastosis virus. J Gen Virol 1972 ; 15 : 183-91.